Charlie Purtell

Charlie Purtell is an accomplished executive with extensive experience in business development, strategic partnerships, and innovation within the life sciences sector. As Vice President of Equity Ventures at Danaher Corporation since January 2018, Purtell has been instrumental in investing in cutting-edge life science tools and diagnostic platforms. Prior roles include Vice President of Open Innovation at Beckman Coulter, Director of Strategic Development at Danaher Corporation, and Global Head of Business Development at Life Technologies. Additionally, Purtell has held significant positions at ARIAD Pharmaceuticals, Incyte Pharmaceuticals, Genencor International, and Lederle Praxis Biologics. Purtell's educational background includes an MBA in Finance from the University of Rochester's Simon Business School and a Bachelor of Science in Biochemistry from the University of Wisconsin-Madison.